Editing by Tyrosinase

Reflecting work in the Lei Lab

Published here November 20, 2026

Tyrosinase-Catalyzed Tyr−Aniline Coupling Enables Peptide Editing, Macrocyclization, and Phage-Display-Based Selection

Wei Ming, Xiang Liu, Xiaoqin Yang, Zehao Zhang, Weikang Zhai, Xindan Zhang, Liwen Bai, and Xinxiang Lei

Journal of the American Chemical Society 2026, 148, 42791−42801. https://doi.org/10.1021/jacs.6c16766

View Original Publication


Tyrosine-selective chemistry has built up a substantial reaction repertoire over the past decade, yet a persistent gap has limited its utility in drug discovery: integrating modular tyrosine modification with macrocycle-library construction and genetically encoded selection remained, as the field acknowledged, largely unexplored. Francis and co-workers established that tyrosinase could oxidize solvent-exposed terminal tyrosine tags on peptides and proteins, enabling site-selective conjugation with aniline derivatives. Wang and co-workers later extended tyrosinase-mediated coupling to intramolecular peptide stapling in predefined sequences. What neither approach addressed was the use of this chemistry as a modular diversification strategy for randomized peptide libraries, leaving a clear opening between residue-selective modification and discovery-oriented screening.

Researchers in the Lei Group at Lanzhou University, published in the Journal of the American Chemical Society, report a tyrosinase-catalyzed tyrosine-aniline coupling platform that unifies peptide macrocyclization and phage-display-based ligand discovery within a single reaction manifold. Based on prior studies, megTyr selectively oxidizes accessible tyrosine residues to o-quinone intermediates, which couple with arylamine nucleophiles under aqueous conditions at room temperature; under optimized conditions in PBS at pH 6.5, conversion approached completion within 3 minutes, though results may not transfer to other buffers, pH values, or temperatures. Bifunctional phenylenediamine linkers extend this chemistry intramolecularly to close macrocycles, and the key advance is translating this single-step cyclization directly onto phage: a monovalent M13 platform, chosen to minimize potential avidity effects, presents tyrosine-flanked randomized peptides as pIII fusions, allowing p-phenylenediamine with catalytic megTyr to macrocyclize an entire library in one treatment.

Applied to Keap1 biopanning, four rounds of selection enriched cyclic peptide CM1, which bound Keap1 with a KD of 211 ± 60 nM by SPR and showed a half-life of 5 hours in 100% mouse plasma compared to less than 30 minutes for its linear precursor. An independent campaign against EphA4 yielded a second cyclic binder, supporting, as the authors state, "the applicability of the platform beyond a single-target system," though the two-target demonstration leaves broader generalizability to future work.


Author

Xinxiang Lei is a Professor of Chemistry at Lanzhou University, China. He received his B.Sc., 2001, from South-Central Minzu University, M.Sc., 2007, from Wenzhou University, and Ph.D., 2012, from the Chengdu Institute of Biology, Chinese Academy of Sciences. After research experience at Yale University, 2010–2011, and Nanjing University, 2013–2014, he held faculty positions at Wenzhou University and South-Central Minzu University before joining Lanzhou University in 2023. His research focuses on anisotropic NMR-based organic structural elucidation, peptide chemical biology, and cyclic-peptide drug discovery.

Editing by Tyrosinase

Author
Wei Ming is a Ph.D. student in the State Key Laboratory of Natural Product Chemistry at Lanzhou University under the supervision of Professor Xinxiang Lei. His research focuses on the development of new strategies for macrocyclic peptide construction and their applications in phage display.